Home
Stempoint Capital reported a 1.5% stake in Vistagen Therapeutics VTGN · 616,749 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 1.5%
- Last report
- 8.2% · filed 25/02/14
- Shares held
- 616,749 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Stempoint Capital
- Event date
- 25/12/31
- Filed
- 26/02/17
1.5% stake · below 5%
- Stake
- 1.5%
- Last report
- 8.2%
- Since last report
- −6.7pp
Vistagen Therapeutics trades, last 26 weeks
What else happened in Vistagen Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Stempoint Capital's other 5% stake reports
- Stempoint Capital
5% stakeXilio Therapeutics
5% stakeXilio Therapeutics
XLO
9.5% stake
628,866 sh
9.5% stake
Filed 08/14
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
5% stake
602,798 sh
5% stake
Filed 08/14
- Stempoint Capital
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
0% stake
0 sh
0% stake
Filed 08/14
- Stempoint Capital
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
9.9% stake
845,740 sh
9.9% stake
Filed 08/14
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
4.5% stake
525,639 sh
4.5% stake
Filed 05/15
